ARTICLE | Clinical News
MA09-hRPE cells: Phase I/II ongoing
July 29, 2013 7:00 AM UTC
Advanced Cell Technology said an independent DSMB recommended continuation of enrollment in the third cohort in an open-label, dose-escalation, U.K. Phase I/II trial evaluating sub-retinal transplanta...